Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 7, 2021Työväentutkimus VuosikirjaOpen Access

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy

View Full Paper
Ask AI
Bookmark
Share

Authors

KPKarita PeltonenUniversity of HelsinkiSFSara FeolaOrion Corporation (Finland)HUHusen M. UmerTallinn University of Technology

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Peltonen et al. (2021) studied this question.

synapsesocial.com/papers/6a94db13397e3dbeede6109bhttps://doi.org/10.3390/cancers13143408
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools2018 · 3,476 citations
  2. 2Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired2009 · 1,791 citations
  3. 3Feasibility study of personalized peptide vaccination for metastatic recurrent triple-negative breast cancer patients2014 · 50 citations
  4. 4PD-L1 Expression in Triple-Negative Breast Cancer2014 · 1,442 citations
  5. 5Immunopeptidomic Profiling of HLA‐A2‐Positive Triple Negative Breast Cancer Identifies Potential Immunotherapy Target Antigens2018 · 48 citations